Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
Recruiting · NCT06532565 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-04-21 | NCT06532565 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Virginia | Fairfax | United States | 83 |
| Princess Margaret Cancer Centre | Toronto | Canada | 1 |
| Stanford Cancer Center | Palo Alto | United States | 11 |
| The Ottawa Hospital Cancer Centre | Ottawa | Canada | 5 |